ストックスクリーナーアプリを入手
0.2876
13.14%
0.035
アフターアワーズ：
.29
0.0024
+0.83%
前日終値:
$0.2526
開ける：
$0.254
24時間の取引高:
1.08M
Relative Volume:
0.06
時価総額：
$18.00M
収益：
$1.16M
当期純損益:
$-37.28M
株価収益率:
-0.4959
EPS:
-0.58
ネットキャッシュフロー:
$-33.81M
1週間 パフォーマンス:
+5.93%
1か月 パフォーマンス:
+14.92%
6か月 パフォーマンス:
+31.10%
1年 パフォーマンス:
-91.59%
1日の値動き範囲:
$0.254
$0.2899
1週間の範囲:
$0.2426
$0.2899
52週間の値動き範囲:
$0.1406
$3.47
Glycomimetics Inc Stock (GLYC) Company Profile
名前
Glycomimetics Inc
セクター
電話
240-243-1201
住所
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
GLYC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLYC
Glycomimetics Inc
|
0.2876 | 18.00M | 1.16M | -37.28M | -33.81M | -0.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-26 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-22 | 開始されました | CapitalOne | Overweight |
| 2021-11-12 | アップグレード | Jefferies | Hold → Buy |
| 2019-11-14 | 開始されました | ROTH Capital | Buy |
| 2019-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-08-05 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | ダウングレード | SunTrust | Buy → Hold |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2018-12-18 | 開始されました | H.C. Wainwright | Buy |
| 2016-07-26 | 開始されました | SunTrust | Buy |
| 2015-03-17 | 繰り返されました | Stifel | Buy |
すべてを表示
Glycomimetics Inc (GLYC) 最新ニュース
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World
Should You Buy GlycoMimetics (GLYC) Ahead of Earnings? - MSN
GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World
GlycoMimetics and Crescent Biopharma Update Investor Presentation in Connection with Proposed Merger - Defense World
GlycoMimetics and Crescent Biopharma Announce Merger Plans - Yahoo Finance
Avacta Appoints Brian Hahn as Chief Financial Officer - The Manila Times
Avacta Appoints Brian Hahn as Chief Financial Officer - GlobeNewswire Inc.
StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
GlycoMimetics (NASDAQ:GLYC) Earns Sell Rating from Analysts at StockNews.com - Defense World
Is It Time For Me To Buy GlycoMimetics Inc (NASDAQ: GLYC) Stock Now? - Stocks Register
GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World
GlycoMimetics, Inc. announced that it expects to receive $200 million in funding - Marketscreener.com
GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World
GlycoMimetics skyrockets on buyout deal - MSN
Logos Global Management LP Acquires 5 Million Shares in GlycoMim - GuruFocus.com
StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
GlycoMimetics: Q3 Earnings Snapshot - Darien Times
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 - Quantisnow
Crescent Biopharma to Showcase Cancer Drug Pipeline at Jefferies Healthcare Conference - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders - The Malaysian Reserve
Finansavisen - Finansavisen
RA Capital Management's Strategic Acquisition of GlycoMimetics I - GuruFocus.com
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting - BioSpace
Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News
Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement - MSN
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - WICZ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders - Marketscreener.com
What Do Wall Street Analysts Think About GlycoMimetics Inc (NASDAQ: GLYC) Stock? - Stocks Register
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc.GLYC - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders - The Malaysian Reserve
GlycoMimetics’ Acquisition of Crescent Biopharma - Global Legal Chronicle
GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today - MSN
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc.GLYC - Business Wire
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
GlycoMimetics Announces Merger Agreement with Crescent Biopharma: A Look at the Details - Defense World
GlycoMimetics To Acquire Crescent Biopharma - FinSMEs
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm - Morningstar
GlycoMimetics soars on news of M&A deal with Crescent Biopharma - The Pharma Letter
GlycoMimetics Announces Merger with Crescent Biopharma - Yahoo Finance
GlycoMimetics Insider Confidence Rewarded, Stock Hits US$11m Market Cap - Simply Wall St
Biotech Up Over +100% Premarket Following Merger And Funding Announcement - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE – ARC) - ForexTV.com
Glycomimetics Inc (GLYC) 財務データ
収益
当期純利益
現金流量
EPS
5.46%
0.79%
大文字化:
|
ボリューム (24 時間):